Financials
- Market Capitalization 1.72 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-4.3
売上高対価格比率
162.41
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2037 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.58 USD | -3.75% | +0.64% | +7.89% | -8.31% | 1.76 B USD | ||
| 2039 | SEPN Septerna, Inc. - Common Stock | 37.56 USD | -2.11% | -1.08% | -2.85% | +70.65% | 1.75 B USD | ||
| 2049 | NUVB Nuvation Bio Inc. Class A Common Stock | 4.90 USD | -2.00% | -1.01% | -16.95% | +34.25% | 1.72 B USD | ||
| 2060 | GPCR Structure Therapeutics Inc - American Depositary Shares | 23.91 USD | -6.38% | -13.21% | -38.57% | -10.58% | 1.71 B USD |